Member Log-in

I forgot my password

Not a Member? Register

Resources

Browse the resource library for research articles, policy briefs, reports, guidebooks, country data, and other resources pertinent to Gavi transition or immunization programs generally.

Some resources are available to LNCT members only and will require sign-in to view.

Discuss

LNCT members can share updates, exchange information, and solicit advice from other country teams or technical facilitators on Gavi transition processes or other immunization topics.

Events

Advanced Course on Health Financing for Universal Coverage for Low and Middle Income Countries by the WHO

06/18/2018 - 06/22/2018

Tunis, Tunisia

Latest News

TVEE Publishes Open Source Health Economics Courses on OpenCourseWare

The Teaching Vaccine Economics Everywhere (TVEE) project is pleased to announce that three modules from its vaccine economics curriculum are now available to the public for free on the JHSPH OpenCourseWare (OCW). The modules published are Health Economics for Vaccines, Costing in Vaccine Planning and Programming, and Economic Evaluation and are available here. Anybody can … Continued

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

A team of researchers modeled the equity impact of lives saved and medical impoverishment averted from immunization over the period 2016-30 in 41 low and middle income countries (DHS survey availability determined which countries were selected for inclusion). Of our 15 LNCT member countries, data from Armenia, Ghana, Indonesia, Nigeria, and Timor-Leste were included in … Continued

New Rotavirus Vaccine Prequalified by WHO

Bharat Biotech announced that ROTAVACĀ® has achieved pre-qualification by the World Health Organization (WHO), making it available for procurement by United Nations agencies and GAVI, the Vaccine Alliance, for use in low-resource countries. ROTAVAC is substantially cheaper than current rotavirus vaccines on the global market and will be available at $1/dose. Read more about ROTAVAC’s … Continued

Choose a Language